We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Preclinical studies investigate gilteritinib's effects on FLT3 mutations in acute myeloid leukemia, implying therapeutic potential.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: